GSK (GSK) Total Assets (2007 - 2026)
GSK (GSK) total assets from Jun 30, 2007 to Mar 31, 2026. The current GSK (GSK) total assets is $110B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
GSK (GSK) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +19.73% |
| 3 Years TTM | +3.98% |
| 5 Years TTM | -5.96% |
| 10 Years TTM | +2.55% |
| All Time TTM | +3.05% |
Annual Total Assets change of GSK (GSK)
| Year | Total Assets | Change |
|---|---|---|
| 2025 | $82B | +10.49% |
| 2024 | $74B | -22.27% |
| 2023 | $96B | +32.11% |
| 2022 | $72B | -49.98% |
| 2021 | $145B | -3.64% |
| 2020 | $150B | +7.36% |
| 2019 | $140B | +89.09% |
| 2018 | $74B | -2.83% |
| 2017 | $76B | +5.06% |
| 2016 | $73B | -7.90% |
| 2015 | $79B | +24.38% |
| 2014 | $63B | -9.14% |
| 2013 | $70B | +3.43% |
| 2012 | $67B | +5.75% |
| 2011 | $64B | -2.92% |
| 2010 | $66B | -5.24% |
| 2009 | $69B | +20.22% |
| 2008 | $58B | -6.37% |
| 2007 | $62B | N/A |
Comparison GSK (GSK) total assets with competitors
GSK (GSK) total assets is $109.62B.
| Ticker | Name | Total Assets | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | $559.22B | +410.16% |
| PFE | Pfizer Inc | $207.62B | +89.40% |
| JNJ | Johnson & Johnson | $200.89B | +83.27% |
| ABBV | Abbvie Inc | $136.46B | +24.49% |
| MRK | Merck & Co Inc | $128.69B | +17.39% |
| SNY | Sanofi | $128.02B | +16.79% |
| NVS | Novartis AG | $118.53B | +8.13% |
| LLY | Lilly(Eli) & Company | $116.58B | +6.35% |
| AZN | Astrazeneca plc | $114.02B | +4.01% |
| AMGN | AMGEN Inc | $92.50B | -15.61% |
| BMY | Bristol-Myers Squibb Company | $86.48B | -21.11% |
| GILD | Gilead Sciences Inc | $56.28B | -48.66% |
| BIIB | Biogen Inc | $29.48B | -73.10% |
| GRFS | Grifols SA | $20.10B | -81.66% |
| OGN | Organon & Company | $13.00B | -88.14% |
| AMRN | Amarin Corp | $645.76M | -99.41% |
| SCLX | Scilex Holding Company | $293.63M | -99.73% |
| MIRA | Mira Pharmaceuticals Inc | $9.46M | -99.99% |
| MDCX | MDCorp | $7.43M | -99.99% |
| MDCXW | Medicus Pharma Ltd warrant | $7.43M | -99.99% |
| NSRX | Nasus Pharma Ltd | $5.00M | -100.00% |